188 related articles for article (PubMed ID: 34672865)
1. Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
Jin Q; Guan L; Pan W; Zhou D
Am J Respir Crit Care Med; 2021 Dec; 204(12):1491-1492. PubMed ID: 34672865
[No Abstract] [Full Text] [Related]
2. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No.
Channick RN; Saggar R
Chest; 2019 Dec; 156(6):1043-1045. PubMed ID: 31812189
[No Abstract] [Full Text] [Related]
3. Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
Sahay S
Chest; 2024 Mar; 165(3):494-496. PubMed ID: 38461012
[No Abstract] [Full Text] [Related]
4. POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
Weatherald J; Sitbon O
Chest; 2024 Mar; 165(3):492-494. PubMed ID: 38461011
[No Abstract] [Full Text] [Related]
5. Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
Bogaard HJ; Sitbon O
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33509909
[No Abstract] [Full Text] [Related]
6. Rebuttal From Drs Channick and Saggar.
Channick RN; Saggar R
Chest; 2019 Dec; 156(6):1047-1048. PubMed ID: 31812191
[No Abstract] [Full Text] [Related]
7. Rebuttal From Drs Humbert and Lau.
Humbert M; Lau EMT
Chest; 2019 Dec; 156(6):1045-1046. PubMed ID: 31812190
[No Abstract] [Full Text] [Related]
8. [Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].
Martynyuk TV; Chazova IE
Ter Arkh; 2021 Sep; 93(9):1009-1017. PubMed ID: 36286859
[TBL] [Abstract][Full Text] [Related]
9. Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension.
Steffes LC; Austin ED
Ann Am Thorac Soc; 2022 Feb; 19(2):163-165. PubMed ID: 35103566
[No Abstract] [Full Text] [Related]
10. Pulmonary Hypertension Associated With Respiratory Diseases - Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
Sakamaki F; Asano K
Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
[No Abstract] [Full Text] [Related]
11. Continued Progress in Therapy for Pulmonary Arterial Hypertension.
Taichman DB; Leopold JA; Elliott G
N Engl J Med; 2023 Apr; 388(16):1524-1526. PubMed ID: 36876747
[No Abstract] [Full Text] [Related]
12. Surrogate endpoints in pulmonary arterial hypertension trials.
Hoeper MM
Lancet Respir Med; 2023 Oct; 11(10):852-853. PubMed ID: 37230096
[No Abstract] [Full Text] [Related]
13. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
[No Abstract] [Full Text] [Related]
14. Initial Triple Pharmacotherapy in Pulmonary Arterial Hypertension: Is More Necessarily Better?
Leopold JA
J Am Coll Cardiol; 2021 Oct; 78(14):1404-1406. PubMed ID: 34593121
[No Abstract] [Full Text] [Related]
15. Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"?
Goncharova EA; Kudryashova TV; Pullamsetti SS
Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37290809
[No Abstract] [Full Text] [Related]
16. Viewpoint: activin signalling inhibitors for the treatment of pulmonary arterial hypertension.
Humbert M
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37918877
[No Abstract] [Full Text] [Related]
17. Prostaglandin I
Norlander AE; Abney M; Cephus JY; Roe CE; Irish JM; Shelburne NJ; Newcomb DC; Hemnes AR; Peebles RS
Am J Respir Crit Care Med; 2023 Sep; 208(6):737-739. PubMed ID: 37413696
[No Abstract] [Full Text] [Related]
18. Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Weatherald J; Moutchia J; Al-Naamani N; McClelland RL; Ventetuolo CE; Palevsky HI; Harhay MO; Kawut SM
Am J Respir Crit Care Med; 2023 Dec; 208(11):1231-1234. PubMed ID: 37734029
[No Abstract] [Full Text] [Related]
19. Update on pediatric pulmonary arterial hypertension.
Ivy D; Frank BS
Curr Opin Cardiol; 2021 Jan; 36(1):67-79. PubMed ID: 33136663
[TBL] [Abstract][Full Text] [Related]
20. To be or not to be… treated with initial combination therapy, that is the (PAH) question.
Boucly A; Humbert M; Sitbon O
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 35654453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
